Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health I... ( MOUNTAIN VIEW Calif. Feb. 19 /- Based...)

Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health Ingredients

Date:2/19/2009

MOUNTAIN VIEW, Calif., Feb. 19 /PRNewswire/ -- Based on its recent analysis of the North American health ingredients market, Frost & Sullivan recognizes Horphag Research Ltd. with the 2008 North American Frost & Sullivan Excellence in Research of the Year Award. The award acknowledges the company's extensive research projects and numerous clinical tests, spread over 40 years, aimed at validating the health benefits of the ingredient, Pycnogenol(R), across industries such as food and beverage ingredients and pharmaceuticals.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

"Pycnogenol(R) is one of the most evidence-based health ingredients with over 220 scientific publications and 80 clinical trials on 7000 patients, confirming its safety, non toxicity, and clinical efficacy since 1975," says Frost & Sullivan Research Analyst Sneha Pasricha. "The published studies have validated Pycnogenol(R)'s role in promoting a wide range of health benefits including cardiovascular, circulatory, cognitive, diabetes, eye, skin, and joint health."

A study in 1975 confirmed Pycnogenol(R)'s potential to reduce edema and pain in the lower legs, while another one in 1986 corroborated Pycnogenol(R)'s protective effects on the eyes. In 1998, numerous studies proved Pycnogenol(R)'s beneficial role in cardiovascular health and normalization of platelet function.

Several studies conducted in 2004 revealed Pycnogenol(R)'s ability to lower blood glucose levels and improve metabolic syndrome and diabetic complications. In 2006, evidence was obtained regarding Pycnogenol(R)'s anti-inflammatory potency in humans that causes relief during menstrual pain and asthma. A series of research efforts in 2008 validated Pycnogenol(R)'s capability to reduce pain and improve joint flexibility in osteoarthritis patients.

0

GOOD

Page: 1 2 3 4
Related medicine news :

1. Frost & Sullivan: Australian Pharmaceuticals and Life Sciences IT Market Is Still Growing
2. Frost & Sullivan Recognizes Strategic Healthcare Programs for Best Practices in Focused Innovation
3. Frost & Sullivan Says, Innovative Therapies Needed to Deal With the Rapid Spread of Cancer in Europe
4. Frost & Sullivan Helps You Know Your End-Market: Medical Trends Impacting the Chemicals and Materials Markets
5. Frost & Sullivan - Consumer Preference for Healthy Bakery
6. Frost & Sullivan Finds Compliance Requirements Drive the Healthcare Security Boom
7. Frost & Sullivan Bestows Product Line Strategy Leadership Award to VTS Medical Systems, LLC
8. Frost & Sullivan Forecasts Increased Demand for Portable and PC-based Ultrasound Units in Eastern Europe
9. Verified Physicians a Must for Ensuring Quality Data From Online Surveys, Finds Frost & Sullivan
10. Ready-To-Use Products Spur the European Tissue Sealants and Topical Hemostats Markets, Says Frost & Sullivan
11. Frost & Sullivan to Host Analyst Briefing on the European Orphan Diseases Market: Niche-Busters - An Attractive Future?

Post Your Comments:

Frost & Sullivan Recognizes Horphag's Pioneering R&D Efforts in Health I...( MOUNTAIN VIEW Calif. Feb. 19 /- Based...),Health